Becton Dickinson & Co. header image

Becton Dickinson & Co.

BDX

Equity

ISIN null / Valor 912061

New York Stock Exchange, Inc (2026-07-02)
USD 158.08+3.39%

Becton Dickinson & Co.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Becton Dickinson & Co. (BD) is a long-established, publicly traded medical technology company headquartered in Franklin Lakes, New Jersey, that designs, manufactures and sells a broad range of medical devices, instrument systems and diagnostic products for healthcare institutions, clinical laboratories, life sciences researchers and pharmaceutical manufacturers. Its offerings include needles and syringes, infusion and medication-delivery systems, catheter and vascular access devices, prefillable drug-delivery systems and related pharmaceutical manufacturing services, as well as diagnostic instruments, specimen collection and preanalytical systems and reagents used in clinical and molecular diagnostics. BD operates globally across multiple business units that serve hospitals, outpatient facilities, labs and biopharma customers, combining product sales with service and technical support for clinical and research workflows.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-10.8%1Y
-40.1%3Y
-36.4%5Y

Performance

31.0%1Y
27.3%3Y
25.0%5Y

Volatility

Market cap

43557 M

Market cap (USD)

Daily traded volume (Shares)

2,040,522

Daily traded volume (Shares)

1 day high/low

227.8 / 225.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Tilray Brands Inc
Tilray Brands Inc Tilray Brands Inc Valor: 42386407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.29%USD 4.62
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.10%USD 4.33
Abbott India Limited
Abbott India Limited Abbott India Limited Valor: 561999
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%INR 25,850.45
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.32%USD 8.39
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.41%USD 114.17
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc Valor: 2649177
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.03%USD 31.45
Astrana Health Inc
Astrana Health Inc Astrana Health Inc Valor: 28041888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.28%USD 49.17
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%USD 19.64
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.99%USD 16.88